Last updated on December 2009

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Brief description of study

In this randomized, controlled trial the investigators evaluate the effects of an exercise program lasting for 12 weeks on the physical performance, the cardiovascular function (24h blood pressure, rest blood pressure and hear function) and the fatigue and mood of patients with renal cell carcinoma undergoing a therapy with Sunitinib.

Clinical Study Identifier: NCT00869011

Contact Investigators or Research Sites near you

Start Over

Fernando C. Dimeo, MD

Section Sports Medicine, Charit Universit tsmedizin Berlin, Hindenburgdamm 30
Berlin, Germany
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.